| Q67654005 | A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis |
| Q43186795 | Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs |
| Q45871980 | Adenovirus-mediated human pancreatic lipase gene transfer to rat bile: gene therapy of fat malabsorption |
| Q38205327 | An overview of the diagnosis and management of nutrition in chronic pancreatitis |
| Q42453045 | Assessment of weight loss, food intake, fat metabolism, malabsorption, and treatment of pancreatic insufficiency in pancreatic cancer |
| Q27013901 | Chronic pancreatitis |
| Q87092580 | Chronic pancreatitis |
| Q43146005 | Chronic pancreatitis: maldigestion, intestinal ecology and intestinal inflammation |
| Q48704817 | Circadian coupling between pancreatic secretion and intestinal motility in humans |
| Q40311657 | Clinical pharmacology for pediatricians. I. Pancreatic enzyme preparations, with special reference to enterically coated microspheres of pancrelipase |
| Q40743359 | Clinical pharmacology of pancreatic enzymes in patients with cystic fibrosis and in vitro performance of microencapsulated formulations |
| Q39166076 | Comparative Effects of Antacids, Cimetidine and Enteric Coating on the Therapeutic Response to Oral Enzymes in Severe Pancreatic Insufficiency |
| Q72400579 | Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy |
| Q71899147 | Comparative effects of antacids, enteric coating, and bile salts on the efficacy of oral pancreatic enzyme therapy in cystic fibrosis |
| Q72510739 | Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine |
| Q42072154 | Comparison of four pancreatic extracts in cystic fibrosis |
| Q41462895 | Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects |
| Q34527545 | Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis |
| Q71949429 | Controversies in the treatment of exocrine pancreatic insufficiency |
| Q45359652 | Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis |
| Q39803118 | Cystic fibrosis and malnutrition |
| Q34765510 | Decrease in pancreatic steatorrhoea by positioned-release enzyme capsules. |
| Q42022559 | Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis |
| Q34386682 | Diagnosis and treatment of pancreatic exocrine insufficiency |
| Q47111954 | ERAS: Improving outcome in the cachectic HPB patient. |
| Q77917946 | Effect of bacterial or porcine lipase with low- or high-fat diets on nutrient absorption in pancreatic-insufficient dogs |
| Q34494540 | Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis |
| Q34527348 | Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis |
| Q34525915 | Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis |
| Q71806092 | Effect of omeprazole on changes in gastric and upper small intestine pH levels in patients with chronic pancreatitis |
| Q71237583 | Effect of pH, substrate, and temperature on tryptic activity of duodenal samples |
| Q74372172 | Effects of high-lipase pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in patients with pancreatic insufficiency resulting from chronic pancreatitis |
| Q36169216 | Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation |
| Q35153883 | Enzyme contents of pancreatic extract preparations. Are they optimal? |
| Q69463412 | Exocrine and endocrine stomach after gastrobulbar preserving pancreatoduodenectomy |
| Q34376692 | Fate of oral enzymes in pancreatic insufficiency |
| Q34052255 | Food intolerance in humans |
| Q51532608 | Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion. |
| Q51606844 | Gut hormones and gastrointestinal motility in children with cystic fibrosis. |
| Q35790597 | Human pancreatic exocrine response to nutrients in health and disease |
| Q34718168 | Impairment of folic acid absorption by oral pancreatic extracts |
| Q50873741 | In vitro comparative study of three pancreatic enzyme preparations: dissolution profiles, active enzyme release and acid stability. |
| Q58168549 | Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution |
| Q38859692 | Infant digestion physiology and the relevance of in vitro biochemical models to test infant formula lipid digestion |
| Q42131908 | Influence of antacid and formulation on effectiveness of pancreatic enzyme supplementation in cystic fibrosis |
| Q39256578 | Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine |
| Q72610594 | Intestinal Concentrations of Pancreatic Enzymes following Pancreatic Replacement Therapy |
| Q35255967 | Is fibrosing colonopathy an immune mediated disease? |
| Q24563472 | Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency |
| Q35832811 | Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency |
| Q38164078 | Maldigestion from pancreatic exocrine insufficiency |
| Q24806288 | Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency |
| Q43219678 | Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test |
| Q44757427 | Monitoring the Effect of Substitution Therapy in Patients with Exocrine Pancreatic Insufficiency |
| Q66893193 | New dimensions in digestive physiology |
| Q35624718 | Non-invasive assessment of intraluminal lipolysis using a 13CO2 breath test |
| Q33741531 | Nutrition supplementation in patients with acute and chronic pancreatitis |
| Q39813548 | Nutritional Problems Induced by Cancer |
| Q66702355 | Oral pancreatic supplements to correct pancreatic malabsorption |
| Q71663045 | Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis |
| Q40564403 | Pancreatic Enzyme Supplementation Therapy |
| Q36837184 | Pancreatic enzyme pharmacotherapy |
| Q34199872 | Pancreatic enzyme replacement therapy |
| Q34137233 | Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century |
| Q46667734 | Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating |
| Q54415061 | Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study. |
| Q36785157 | Pancreatic enzyme therapy for pancreatic exocrine insufficiency. |
| Q40758310 | Pancreatic enzymes in chronic pancreatitis |
| Q37842755 | Pancreatic exocrine insufficiency: diagnosis and treatment. |
| Q34393107 | Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice |
| Q49841510 | Pancreatitis-induced Depletion of Syntaxin 2 Promotes Autophagy and Increases Basolateral Exocytosis |
| Q68940388 | Pathogenesis of steatorrhea in primary biliary cirrhosis |
| Q46380953 | Physiological basis of cystic fibrosis: a historical perspective |
| Q43667927 | Postcibal gastric emptying of pancreatin pellets: effects of dose and meal oil. |
| Q34475186 | Postprandial gastric function in pancreatic insufficiency |
| Q42322542 | Practical guide to exocrine pancreatic insufficiency - Breaking the myths |
| Q93090831 | Rational Use of Pancreatic Enzymes for Pancreatic Insufficiency and Pancreatic Pain |
| Q52878106 | Rationale of modern dietary recommendations in cystic fibrosis. |
| Q90192795 | Role of Fibre in Nutritional Management of Pancreatic Diseases |
| Q33446297 | Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study |
| Q34325122 | Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area |
| Q72429336 | Solubility of oral pancreatic enzyme supplement capsules in biological fluids |
| Q93646430 | Spontaneous improvement in pancreatic function in chronic pancreatitis |
| Q72161424 | Steatorrhea in Japanese patients with chronic pancreatitis |
| Q72717465 | Studies on the quality of pancreatic preparations: Enzyme content, prospective bioavailability, bile acid pattern, and contamination with purines |
| Q54388553 | Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations. |
| Q72623708 | The Effect of Enzyme Substitution in Patients with Pancreatic Insufficiency |
| Q36101263 | The daily practice of pancreatic enzyme replacement therapy after pancreatic surgery: a northern European survey: enzyme replacement after surgery |
| Q41454918 | The effect of cimetidine on maldigestion in cystic fibrosis |
| Q70995761 | The treatment of malabsorption in cystic fibrosis with pancreatic extracts and inhibition of gastric acidity by antacids and cimetidine |
| Q35624671 | Two enteric coated microspheres in cystic fibrosis |
| Q52865173 | Update on intestinal strictures. |
| Q68018671 | Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. A long-term study in cystic fibrosis |
| Q67928589 | Use of pancreatic Schilling test to determine efficiency of pancreatic enzyme delivery in pancreatic insufficiency |
| Q77111271 | Uses and abuses of enzyme therapy in cystic fibrosis |
| Q68558715 | Volume and enzyme kinetics of human pancreatic secretion after endogenous stimulation with the Lundh test meal |
| Q81231443 | [Diagnosis and therapy of chronic pancreatitis] |
| Q82734897 | [Digestive complications in adults with cystic fibrosis] |